Indivior Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 18.54 M | $565.17 M | 100.00% | 14.83% |
| 05/08/2026 | 7.89 M | $240.54 M | 100.00% | 6.31% | |
| OAKTREE CAPITAL MANAGEMENT LP | 05/20/2026 | 6.98 M | $212.88 M | 100.00% | 5.59% |
| 05/15/2026 | 5.59 M | $170.28 M | 100.00% | 4.47% | |
| STATE STREET CORP | 05/15/2026 | 4.90 M | $149.47 M | 100.00% | 3.92% |
| TWO SEAS CAPITAL LP | 05/15/2026 | 4.75 M | $144.67 M | 100.00% | 3.80% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 4.60 M | $140.07 M | 100.00% | 3.68% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 05/14/2026 | 4.53 M | $138.06 M | 100.00% | 3.62% |
| MADISON AVENUE PARTNERS, LP | 05/15/2026 | 4.32 M | $131.53 M | -31.29% | 3.45% |
| CITADEL ADVISORS LLC | 05/15/2026 | 3.57 M | $108.94 M | 100.00% | 2.86% |
| MORGAN STANLEY | 05/15/2026 | 3.51 M | $106.86 M | 100.00% | 2.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 3.10 M | $94.42 M | 100.00% | 2.48% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.93 M | $89.19 M | 100.00% | 2.34% |
| MANGROVE PARTNERS | 05/15/2026 | 2.74 M | $83.59 M | 100.00% | 2.19% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 2.41 M | $73.43 M | 100.00% | 1.93% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 05/14/2026 | 2.32 M | $70.81 M | 100.00% | 1.86% |
| UBS GROUP AG | 05/05/2026 | 2.19 M | $66.82 M | 100.00% | 1.75% |
| NEWTYN MANAGEMENT, LLC | 05/15/2026 | 2.00 M | $60.96 M | 100.00% | 1.60% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2026 | 1.88 M | $57.30 M | -6.01% | 1.50% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 05/14/2026 | 1.84 M | $55.93 M | 100.00% | 1.47% |
| BARCLAYS PLC | 05/15/2026 | 1.75 M | $53.21 M | 100.00% | 1.40% |
| INVESCO LTD. | 05/12/2026 | 1.56 M | $47.60 M | 100.00% | 1.25% |
| ACADIAN ASSET MANAGEMENT LLC | 05/13/2026 | 1.39 M | $42.39 M | 100.00% | 1.11% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 1.33 M | $40.59 M | 100.00% | 1.07% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 1.27 M | $38.83 M | 100.00% | 1.02% |
| FEDERATED HERMES, INC. | 05/11/2026 | 1.22 M | $37.12 M | 100.00% | 0.97% |
| NORTHERN TRUST CORP | 05/14/2026 | 1.16 M | $35.40 M | 100.00% | 0.93% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 1.14 M | $34.80 M | 100.00% | 0.91% |
| GENDELL JEFFREY L | 05/15/2026 | 1.10 M | $33.42 M | 100.00% | 0.88% |
| NUVEEN, LLC | 04/30/2026 | 930.91 K | $28.37 M | 100.00% | 0.74% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 858.18 K | $26.16 M | 100.00% | 0.69% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 828.89 K | $25.26 M | 100.00% | 0.66% |
| PRINCIPAL FINANCIAL GROUP INC | 05/04/2026 | 767.38 K | $23.39 M | 100.00% | 0.61% |
| CLARET ASSET MANAGEMENT CORP | 05/11/2026 | 707.27 K | $21.56 M | 100.00% | 0.57% |
| MELQART ASSET MANAGEMENT (UK) LTD | 05/12/2026 | 684.32 K | $20.86 M | 100.00% | 0.55% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 682.78 K | $20.81 M | 100.00% | 0.55% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 667.13 K | $20.33 M | 100.00% | 0.53% |
| RUBRIC CAPITAL MANAGEMENT LP | 05/15/2026 | 662.52 K | $20.19 M | 100.00% | 0.53% |
| OBERWEIS ASSET MANAGEMENT INC/ | 05/15/2026 | 653.41 K | $19.92 M | 100.00% | 0.52% |
| PFM HEALTH SCIENCES, LP | 05/15/2026 | 574.67 K | $17.52 M | 100.00% | 0.46% |
| JPMORGAN CHASE & CO | 05/13/2026 | 539.86 K | $15.54 M | 100.00% | 0.43% |
| FMR LLC | 05/15/2026 | 527.71 K | $16.08 M | 100.00% | 0.42% |
| DIVISADERO STREET CAPITAL MANAGEMENT, LP | 05/15/2026 | 521.08 K | $15.88 M | 100.00% | 0.42% |
| JEFFERIES FINANCIAL GROUP INC. | 05/08/2026 | 507.91 K | $15.48 M | 100.00% | 0.41% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 05/13/2026 | 446.64 K | $13.61 M | 100.00% | 0.36% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 429.36 K | $13.09 M | 100.00% | 0.34% |
| ALTA FUNDAMENTAL ADVISERS LLC | 05/05/2026 | 409.53 K | $12.48 M | 100.00% | 0.33% |
| LSV ASSET MANAGEMENT | 05/11/2026 | 373.73 K | $11.39 M | 100.00% | 0.30% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 364.21 K | $11.10 M | 100.00% | 0.29% |
| KRENSAVAGE ASSET MANAGEMENT, LLC | 05/15/2026 | 339.53 K | $10.35 M | 100.00% | 0.27% |
Indivior Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 332 institutional investors and hedge funds held shares of Indivior Pharmaceuticals Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 18.54 M
OAKTREE CAPITAL MANAGEMENT LP: 6.98 M
STATE STREET CORP: 4.9 M
Two Seas Capital LP: 4.75 M
MILLENNIUM MANAGEMENT LLC: 4.6 M
FULLER & THALER ASSET MANAGEMENT, INC.: 4.53 M
102.18% of Indivior Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 121.11 M shares in the last 24 months. This purchase volume represents approximately $3.95 B in transactions.